Merck & Co., Inc. — Director's Dealing 2025

May 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-29

Reporting Person: Davis Robert M (Director, Chairman, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-29	Restricted Stock Unit	$	A	39901	Acquired	2028-04-29	Common Stock (39901)	Direct
2025-04-29	Stock Option (Right to Buy)	$84.71	A	181623	Acquired	2035-04-28	Common Stock (181623)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	443601.757	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

F3: The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.